These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
127 related articles for article (PubMed ID: 12134592)
21. 5-HT2 receptor antagonist-mediated inhibition of halothane-induced contractures in skeletal muscle specimens from malignant hyperthermia susceptible patients. Wappler F; Scholz J; Fiege M; Richter A; Steinfath M; Weisshorn R; Schulte am Esch J Naunyn Schmiedebergs Arch Pharmacol; 1999 Oct; 360(4):376-81. PubMed ID: 10551274 [TBL] [Abstract][Full Text] [Related]
22. Ritanserin attenuates the in vitro effects of the 5-HT2 receptor agonist DOI on skeletal muscles from malignant hyperthermia-susceptible patients. Wappler F; Scholz J; Oppermann S; von Richthofen V; Steinfath M; Schulte am Esch J J Clin Anesth; 1997 Jun; 9(4):306-11. PubMed ID: 9195354 [TBL] [Abstract][Full Text] [Related]
24. Is there a link between exertional heat stroke and susceptibility to malignant hyperthermia? Sagui E; Montigon C; Abriat A; Jouvion A; Duron-Martinaud S; Canini F; Zagnoli F; Bendahan D; Figarella-Branger D; Brégigeon M; Brosset C PLoS One; 2015; 10(8):e0135496. PubMed ID: 26258863 [TBL] [Abstract][Full Text] [Related]
25. Cystathionine β-synthase-derived hydrogen sulfide is involved in human malignant hyperthermia. Vellecco V; Mancini A; Ianaro A; Calderone V; Attanasio C; Cantalupo A; Andria B; Savoia G; Panza E; Di Martino A; Cirino G; Bucci M Clin Sci (Lond); 2016 Jan; 130(1):35-44. PubMed ID: 26460077 [TBL] [Abstract][Full Text] [Related]
26. Effects of the phosphodiesterase-III inhibitor enoximone on skeletal muscle specimens from malignant hyperthermia susceptible patients. Fiege M; Wappler F; Scholz J; Weisshorn R; von Richthofen V; Schulte am Esch J J Clin Anesth; 2000 Mar; 12(2):123-8. PubMed ID: 10818326 [TBL] [Abstract][Full Text] [Related]
27. Porcine malignant hyperthermia: halothane effects on force generation in skeletal muscles. Gallant EM; Goettl VM Muscle Nerve; 1989 Jan; 12(1):56-63. PubMed ID: 2747737 [TBL] [Abstract][Full Text] [Related]
28. Comparison of the segregation of the RYR1 C1840T mutation with segregation of the caffeine/halothane contracture test results for malignant hyperthermia susceptibility in a large Manitoba Mennonite family. Serfas KD; Bose D; Patel L; Wrogemann K; Phillips MS; MacLennan DH; Greenberg CR Anesthesiology; 1996 Feb; 84(2):322-9. PubMed ID: 8602662 [TBL] [Abstract][Full Text] [Related]
29. Effects of halothane and isoflurane on the contraction, relaxation and energetics of rat diaphragmatic muscle. Bouhemad B; Langeron O; Orliaguet G; Coriat P; Riou B Br J Anaesth; 2002 Sep; 89(3):479-85. PubMed ID: 12402729 [TBL] [Abstract][Full Text] [Related]
30. Treatment of normal skeletal muscle with FK506 or rapamycin results in halothane-induced muscle contracture. Brooksbank RL; Badenhorst ME; Isaacs H; Savage N Anesthesiology; 1998 Sep; 89(3):693-8. PubMed ID: 9743407 [TBL] [Abstract][Full Text] [Related]
31. In vivo whole-body resting energy expenditure and insulin action in human malignant hyperthermia. Freymond D; Dériaz O; Frascarolo P; Reiz S; Jéquier E; Urwyler A Anesthesiology; 2000 Jul; 93(1):39-47. PubMed ID: 10861144 [TBL] [Abstract][Full Text] [Related]
32. [Effect of chlorocresol vs caffeine on muscle contracture in malignant hyperthermia susceptible patients]. Ben-Abraham R; Krivosic-Horber RM; Haudcoeur G; Perel A; Adnet PJ Harefuah; 1997 Jun; 132(12):839-41, 911. PubMed ID: 9264187 [TBL] [Abstract][Full Text] [Related]
33. [Caffeine skinned fiber tension test: application to the diagnosis of susceptibility to malignant hyperthermia]. Adnet P; Börtlein ML; Tavernier B; Nivoche Y; Etchrivi T; Krivosic-Horber R; Haudecoeur G Ann Fr Anesth Reanim; 1999 Jun; 18(6):624-30. PubMed ID: 10464528 [TBL] [Abstract][Full Text] [Related]
34. Sources of variability in halothane and caffeine contracture tests for susceptibility to malignant hyperthermia. Ording H; Bendixen D Eur J Anaesthesiol; 1992 Sep; 9(5):367-76. PubMed ID: 1396623 [TBL] [Abstract][Full Text] [Related]
35. [4-chloro-m-cresol-induced contractures of skeletal muscle specimen from patients at risk for malignant hyperthermia]. Wappler F; Scholz J; von Richthofen V; Fiege M; Steinfath M; Schulte am Esch J Anasthesiol Intensivmed Notfallmed Schmerzther; 1997 Sep; 32(9):541-8. PubMed ID: 9417254 [TBL] [Abstract][Full Text] [Related]
36. Extending the skeletal muscle viability period in the malignant hyperthermia test. Bina S; Holman S; Muldoon SM Anesth Analg; 2003 Jan; 96(1):153-8, table of contents. PubMed ID: 12505942 [TBL] [Abstract][Full Text] [Related]